We often don’t know what we are doing, but we can’t stop. Science and research never stop.

Curing disease, growing organs, and even teaching organoids to play a computer game are sending seismic waves of hope within the research community as the potential increases exponentially.

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

The first installment lays the foundation for understanding how CAR T works. This second piece delves into the use of CAR T to treat B cell cancers.